[Prognostic value of biomarkers in chronic heart failure with preserved left ventricular ejection fraction]

Autor:	Abram Syrkin, D. Yu. Shchekochikhin, F. Yu. Kopylov, T A Nikiforova
Rok vydání:	2017
Předmět:	History medicine.medical_specialty animal structures medicine.drug_class Endocrinology Diabetes and Metabolism Galectin 3 lcsh:Medicine c-type natriuretic peptide (cnp) 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Internal medicine urodilatin galectin-3 Natriuretic Peptide Brain medicine Natriuretic peptide Humans In patient 030212 general & internal medicine chronic heart failure with preserved ejection fraction Heart Failure Ejection fraction biology natriuretic peptide business.industry lcsh:R Stroke Volume General Medicine Stroke volume medicine.disease Prognosis growth- stimulating factor (st2) Cystatin C Galectin-3 Heart failure cystatin c Cardiology biology.protein Family Practice business d-type natriuretic peptide Biomarkers
Zdroj:	Терапевтический архив, Vol 88, Iss 9, Pp 102-105 (2016)
ISSN:	0040-3660
Popis:	The paper reviews major biomarkers for determining the prognosis in patients with chronic heart failure and preserved ejection fraction. It also considers cystatin C, one of the novel and probably the most practically important biomarkers.Представлен обзор основных биомаркеров, определяющих прогноз у пациентов с хронической сердечной недостаточностью и сохраненной фракцией выброса. В том числе рассмотрен один из новых и, вероятно, наиболее практически значимый биомаркер - цистатин С.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1349986f17c8f7e964c97c0d088c3bb1 https://pubmed.ncbi.nlm.nih.gov/28635812 Zobrazit plný text záznamu